Neopenda

Neopenda is a medical device company for high-growth emerging markets, starting with a vitalsigns monitor for critically ill newborns. We will sell our devices to hospitals and NGOs in emerging markets.

Invest $100 - We will give you a personal shout out on our website (with your consent)!
Invest $500 - All of the above + we’ll add your name to our “plaque” of supporters in our office
Invest $1,000 - All of the above + you’ll receive a Neopenda t-shirt.
Invest $5,000 - All of the above + a Neopenda photo book telling the story of our work in Uganda.
Invest $10,000 - All of the above + dinner with the founders at our HQ in Chicago.

Medical device company with potential to save up to 2.6M newborn lives a year in emerging economies
$7.1B Target market by 2023: Medical devices in Africa
Patent pending and additional provisional patents filed
Founders are biomedical engineers out of Columbia University
Techstars Chicago Class of 2018
$770k raised to date from Columbia University, Cisco, Vodafone, ADAP Capital, Techstars, and others
A for-profit Public Benefit Corporation
Become part of Neopenda’s journey for as little as $100, and see how a little goes a long way in saving lives

• Intermediary Fees 6.00%
• Campaign marketing expenses or related reimbursement 0.93%
• Estimated Attorney Fees 2.80%
• Estimated Accountant/Audi tor Fees  2.80%
• General Marketing 1.87%
• Research and Development 22.04%
• Manufacturing  23.36%
• Equipment Purchases 2.80%
• Clinical study implementation 18.7%
• Regulatory approval 18.7%

Sona Shah
Co-founder and CEO
Chief Executive Officer- manages business development and operations for Neopenda.

Teresa Cauvel
Co-founder and CTO
Chief Technology Officer- Teresa leads product management and technology development at Neopenda. She regularly coordinates consultants and receives feedback from users and stakeholders.

• Type of security: Crowd Safe · Learn more
• Discount: 20%
• Valuation cap: $6,000,000